You are here: Industry Insights > Patheon

News List

Thermo Fisher acquires PPD, a CRO, in $17.4 billion deal expresspharma
April 19, 2021
Thermo Fisher Scientific said it would acquire contract researcher PPD for $17.4 billion as it looks to add more muscle to its pharmaceutical services business.
Cantargia, Patheon Biologics Sign Supply Agreement contractpharma
May 21, 2019
Secures production of antibody CAN04 for clinical trials.
Thermo Fisher Scientific Completes Acquisition of Patheon pharmaceutical-technology
August 31, 2017
Thermo Fisher Scientific has completed its acquisition of Patheon, a contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion.
Patheon to invest $45 million in spray drying & manufacturing solutions europeanpharmaceuticalreview
July 06, 2017
Patheon expects to invest approximately $45 million at key sites across its network in spray drying capabilities and flexible manufacturing solutions…
Patheon to invest $45 million, expanding capabilities to support continued growth cphi-online
July 04, 2017
Investments in commercial and development spray drying, and flexible manufacturing solutions.
Patheon to Invest $45M to Expand Capabilities contractpharma
June 30, 2017
Will invest in commercial and development spray drying and flexible manufacturing solutions
Thermo Fisher Scientific to acquire Patheon cphi-online
May 25, 2017
Patheon provides entry into the attractive, high-growth CDMO market.
Thermo Fisher to Buy Patheon for $7.2B contractpharma
May 16, 2017
Provides entry into the high-growth CDMO market
Patheon Completes NC Sterile Expansion contractpharma
May 09, 2017
Patheon Completes NC Sterile Expansion, Invests $26 million in new sterile PDS suite